Use, Safety, and Efficacy of Single-Patient Use of the US Food and Drug Administration Expanded Access Program.
2019
This study assesses the outcomes of single-patient use of the US Food and Drug Administration Expanded Access program.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
5
References
6
Citations
NaN
KQI